Search Results

You are looking at 1 - 10 of 26 items for :

  • "Marginal zone lymphoma" x
  • Refine by Access: All x
Clear All
Full access

Marginal Zone Lymphoma

Omid S. Shaye and Alexandra M. Levine

– 3834 . 48. Chacon JI Mollefo M Munoz E . Splenic marginal zone lymphoma: Clinical characteristics and prognostic factors in a series of 60 patients . Blood 2002 ; 100 : 1648 – 1654 . 49. Troussard X Valenci F Duchayne E

Full access

Challenges and Opportunities in Marginal Zone Lymphoma: Implications of Biology on Treatment

Presented by: Stephen D. Smith

Marginal zone lymphoma (MZL) is a heterogeneous group of diseases, but they share common features in terms of etiology and even clinical presentation. Given favorable rates of long-term survival, sequencing and therapy selection play an important

Full access

Idelalisib and Rituximab in 17p Deletion–Positive Splenic Marginal Zone Lymphoma

Aby Z. Philip

Splenic marginal zone lymphoma (SMZL) is a rare low-grade B-cell lymphoma considered a distinct entity in the WHO classification. 1 SMZL accounts for approximately 0.6% of all non-Hodgkin's lymphomas (NHLs), according to the SEER registries, and

Full access

Updates to the Management of Patients With Relapsed or Refractory Indolent Follicular and Marginal Zone Lymphomas

Presented by: Ann S. LaCasce and Ariela Noy

durable remission, making this an appealing option for young patients.” According to Dr. LaCasce, providers must consider a variety of patient and disease factors when applying these results to individual patients. R/R Marginal Zone Lymphoma MZL

Full access

Gastric MALT Lymphoma Treated With Primary Radiotherapy in the Setting of Autoimmune Disease

Chelsea C. Pinnix, Valerie Reed, and Bouthaina Dabaja

Marginal zone lymphoma (MZL) describes 3 indolent B-cell non-Hodgkin's lymphomas (NHL): splenic MZL, nodal MZL, and extranodal MZL (of mucosa-associated lymphoid tissue [MALT]). Although all 3 share a common cell of origin, the marginal zone B

Full access

Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin’s Lymphoma

Scott F. Huntington, Jessica R. Hoag, Rong Wang, Amer M. Zeidan, Smith Giri, Steven D. Gore, Xiaomei Ma, Cary P. Gross, and Amy J. Davidoff

, diffuse large B-cell lymphoma; NHL, non-Hodgkin’s lymphoma; MZL, marginal zone lymphoma. Construction of Variables Exposure and Outcome The Healthcare Common Procedure Coding System (HCPCS) code J9310 was used to identify receipt of rituximab from Medicare

Full access

Non-Hodgkin's Lymphoma Clinical Practice Guidelines

Memorial Sloan-Kettering Cancer Center

Non-Hodgkin's lymphomas (NHLs) may be classified on the basis of morphology, natural history, and immunophenotypic and molecular characteristics. These guidelines were developed for more common NHL histologic types, including chronic lymphocytic leukemia/small lymphocytic lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma, and for less common entities with unique natural histories and therapies, such as marginal zone lymphoma, mantle cell lymphoma, and highly aggressive lymphoma subtypes, including Burkitt's, and lymphoblastic lymphomas and AIDS-related B-cell lymphomas. Certain components of the diagnosis and therapy of the various NHLs are similar. In all cases, an accurate pathologic diagnosis must first be made.

For the most recent version of the guidelines, please visit NCCN.org

Full access

Oncology Research Program

and Marginal Zone Lymphoma Principal Investigator: Stephen D. Smith, MD Conditions: Marginal zone lymphoma, recurrent marginal zone lymphoma, recurrent Waldenström's macroglobulinemia, refractory marginal zone lymphoma, refractory Waldenström

Full access

Ten Years of Progress in the Treatment of Non-Hodgkin’s Lymphoma

Julie M. Vose

/small lymphocytic lymphoma or the t(11;18) in gastric marginal zone lymphoma. Various prognostic factor indices have been developed over this time, including the Follicular Lymphoma International Prognostic Index (FLIPI) and the Mantle Cell Prognostic Factor Index

Full access

NCCN News

’s New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood Cancer NCCN has published new Guidelines for Patients: Marginal Zone Lymphoma . A cancer of the lymphatic system, marginal zone